TROP2 in colorectal carcinoma: associations with histopathology, molecular phenotype, and patient prognosis

Foersch S, Schmitt M, Litmeyer AS, et al. TROP2 in colorectal carcinoma: associations with histopathology, molecular phenotype, and patient prognosis (PMID: 39177576). J Pathol Clin Res. 2024.

High CIB1 expression in colorectal cancer liver metastases correlates with worse survival and the replacement histopathological growth pattern

Fan S, Fleischer JR, Dokshokova L, et al. High CIB1 expression in colorectal cancer liver metastases correlates with worse survival and the replacement histopathological growth pattern (PMID: 39072289). Mol Ther Oncol. 2024.

Metavert synergises with standard cytotoxics in human PDAC organoids and is associated with transcriptomic signatures of therapeutic response

An J, Kurilov R, Peccerella T, et al. Metavert synergises with standard cytotoxics in human PDAC organoids and is associated with transcriptomic signatures of therapeutic response (PMID: 39217851). Transl Oncol. Epub 2024

Is this what the future of cancer research looks like?

Cancer: Researchers search for reasons for therapy resistance

Mamma Mia! Explanatory videos on CATCH / COGNITION

Interview Andreas Trumpp: Overcoming resistance

FutureXChange – The Future Forum of the National Decade Against Cancer Project pitch SATURN3 by Jens Siveke

Focus on tumor heterogeneity in difficult-to-treat cancers

Better combating resistant cancer cells